Kintor Pharmaceutical Limited
HKEX:9939.HK
1.13 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2017 Q4 | 2017 Q2 | 2016 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 445.499 | 0.691 | 0.865 | 0.337 | 0.93 | 1.233 | 1.066 | 1.792 | 0.196 | 13.193 | 34.442 | 9.64 |
Short Term Investments
| 10 | 0.011 | 0.012 | 0.01 | 0.127 | 0.522 | 0.328 | 0 | 0.001 | 16 | 0 | 0 |
Cash and Short Term Investments
| 455.499 | 0.702 | 0.877 | 0.387 | 1.057 | 1.755 | 1.393 | 1.792 | 0.197 | 29.193 | 34.442 | 9.64 |
Net Receivables
| 0 | 0 | 0 | -0.04 | 0 | 0 | 0 | 0 | 0 | 0.641 | 0.294 | 0.284 |
Inventory
| 0 | 0.603 | 0.604 | 0.606 | 0.351 | 0.026 | 0 | 0 | 0 | -0 | 0.253 | 0.15 |
Other Current Assets
| 0.015 | 0.034 | 0.027 | 0.224 | 0.118 | 0.141 | 0.027 | 0.015 | 0.024 | 4.926 | 5.589 | 2.981 |
Total Current Assets
| 472.557 | 1.339 | 1.508 | 1.177 | 1.526 | 1.923 | 1.421 | 1.807 | 0.221 | 34.76 | 40.577 | 13.055 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 190.713 | 0.273 | 0.282 | 0.279 | 0.262 | 0.235 | 0.187 | 0.153 | 0.113 | 4.202 | 3.779 | 3.883 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 180.07 | 0.236 | 0.236 | 0.236 | 0.236 | 0.21 | 0.21 | 0.179 | 0.179 | 9.817 | 0.004 | 0.004 |
Goodwill and Intangible Assets
| 180.07 | 0.236 | 0.236 | 0.236 | 0.236 | 0.21 | 0.21 | 0.179 | 0.179 | 9.817 | 0.004 | 0.004 |
Long Term Investments
| 0.018 | 0.018 | 0.018 | 0.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 25.866 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.008 | -0.526 | -0.536 | -0.534 | 0 | -0.445 | -0.396 | -0.333 | -0.292 | 0.357 | 0.028 | 0.007 |
Total Non-Current Assets
| 396.675 | 0.526 | 0.536 | 0.534 | 0.498 | 0.445 | 0.396 | 0.333 | 0.292 | 14.376 | 3.811 | 3.895 |
Total Assets
| 869.232 | 1.874 | 2.055 | 1.75 | 2.068 | 2.401 | 1.851 | 2.177 | 0.553 | 49.136 | 44.389 | 16.95 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 68.288 | 0.14 | 0.18 | 0.251 | 0.173 | 0.033 | 0.029 | 0.041 | 0.023 | 0 | 0 | 0 |
Short Term Debt
| 118.23 | 104.774 | 103.335 | 56.586 | 9.469 | 7.594 | 86.313 | 112.748 | 61.786 | 15 | 17 | 0 |
Tax Payables
| 0.432 | 1.084 | 1.899 | 2.948 | 2.097 | 1.151 | 1.179 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 38.183 | -104.774 | -103.335 | -56.586 | -9.469 | -7.594 | -86.313 | -112.748 | -61.786 | 0 | 0 | 0 |
Other Current Liabilities
| 0.029 | 0.134 | 0.138 | 0.092 | 0.047 | 0.037 | 0.141 | 0.197 | 0.119 | 0.505 | 0.551 | 0.1 |
Total Current Liabilities
| 224.73 | 0.274 | 0.318 | 0.342 | 0.22 | 0.07 | 0.169 | 0.238 | 0.143 | 15.505 | 17.551 | 0.1 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 135.69 | 0.214 | 0.178 | 0.17 | 0.148 | 0.132 | 0.135 | 0.099 | 2.311 | 30 | 0 | 0 |
Deferred Revenue Non-Current
| 19.657 | 18.132 | 19.952 | 3.611 | 4.009 | -38.686 | -38.683 | -38.72 | -38.818 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 31.043 | 38.818 | 38.818 | 38.818 | 38.818 | 38.818 | 38.818 | 38.818 | 38.818 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | -56.95 | -58.77 | -42.429 | -42.827 | -0.132 | -0.135 | -0.099 | 38.818 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 186.39 | 0.214 | 0.178 | 0.17 | 0.148 | 0.132 | 0.135 | 0.099 | 41.129 | 30 | 0 | 0 |
Total Liabilities
| 411.12 | 0.549 | 0.56 | 0.563 | 0.413 | 0.241 | 0.344 | 0.376 | 0.184 | 45.505 | 17.551 | 0.1 |
Equity: | ||||||||||||
Preferred Stock
| 3,784.664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.655 | 19.655 | 18.781 |
Retained Earnings
| -3,784.664 | -2.936 | -2.724 | -2.288 | -1.769 | -1.253 | -0.927 | -0.615 | -0.419 | -104.087 | -80.88 | -57.87 |
Accumulated Other Comprehensive Income/Loss
| 0.458 | 0.084 | 0.115 | 3.475 | 65.489 | 3,412.978 | 2,435.053 | 2,415.059 | 788.726 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 457.339 | 4.177 | 4.104 | 0 | -62.065 | -3,409.565 | -2,432.618 | -2,412.644 | -787.937 | 88.062 | 88.062 | 55.939 |
Total Shareholders Equity
| 458.112 | 1.326 | 1.495 | 1.188 | 1.655 | 2.16 | 1.508 | 1.801 | 0.37 | 3.631 | 26.838 | 16.849 |
Total Equity
| 458.112 | 1.326 | 1.495 | 1.188 | 1.655 | 2.16 | 1.508 | 1.801 | 0.37 | 3.631 | 26.838 | 16.849 |
Total Liabilities & Shareholders Equity
| 869.232 | 1,874.14 | 2,055.136 | 1,750.38 | 2,067.989 | 2,400.919 | 1,851.475 | 2,177.123 | 553.376 | 49.136 | 44.389 | 16.95 |